343 related articles for article (PubMed ID: 23310951)
21. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR
J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
[TBL] [Abstract][Full Text] [Related]
22. The autoantibody repertoire in periodontitis: a role in the induction of autoimmunity to citrullinated proteins in rheumatoid arthritis?
de Pablo P; Dietrich T; Chapple IL; Milward M; Chowdhury M; Charles PJ; Buckley CD; Venables PJ
Ann Rheum Dis; 2014 Mar; 73(3):580-6. PubMed ID: 23434568
[TBL] [Abstract][Full Text] [Related]
23. The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis.
Van Steendam K; Tilleman K; Deforce D
Rheumatology (Oxford); 2011 May; 50(5):830-7. PubMed ID: 21278075
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis: diagnostic accuracy of the citrullinated peptides derived from fibrinogen and vimentin in rheumatoid arthritis.
Li X; Wang Z; Yi H; Xie J; Zhu N
Clin Rheumatol; 2020 Apr; 39(4):1111-1120. PubMed ID: 31858337
[TBL] [Abstract][Full Text] [Related]
25. Association of levels of antibodies against citrullinated cyclic peptides and citrullinated α-enolase in chronic and aggressive periodontitis as a risk factor of Rheumatoid arthritis: a case control study.
Reichert S; Schlumberger W; Dähnrich C; Hornig N; Altermann W; Schaller HG; Schulz S
J Transl Med; 2015 Aug; 13():283. PubMed ID: 26319714
[TBL] [Abstract][Full Text] [Related]
26. Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis.
Shi J; van de Stadt LA; Levarht EW; Huizinga TW; Hamann D; van Schaardenburg D; Toes RE; Trouw LA
Ann Rheum Dis; 2014 Apr; 73(4):780-3. PubMed ID: 24336334
[TBL] [Abstract][Full Text] [Related]
27. Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients.
Barra L; Scinocca M; Saunders S; Bhayana R; Rohekar S; Racapé M; Coles R; Cairns E; Bell DA
Arthritis Rheum; 2013 Jun; 65(6):1439-47. PubMed ID: 23450693
[TBL] [Abstract][Full Text] [Related]
28. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis.
Kinloch A; Lundberg K; Wait R; Wegner N; Lim NH; Zendman AJ; Saxne T; Malmström V; Venables PJ
Arthritis Rheum; 2008 Aug; 58(8):2287-95. PubMed ID: 18668562
[TBL] [Abstract][Full Text] [Related]
29. Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis.
Johansson L; Pratesi F; Brink M; Ärlestig L; D'Amato C; Bartaloni D; Migliorini P; Rantapää-Dahlqvist S
Arthritis Res Ther; 2016 Jun; 18(1):127. PubMed ID: 27255888
[TBL] [Abstract][Full Text] [Related]
30. Loss-of-function mutations in the filaggrin gene: no contribution to disease susceptibility, but to autoantibody formation against citrullinated peptides in early rheumatoid arthritis.
Hüffmeier U; Böiers U; Lascorz J; Reis A; Burkhardt H
Ann Rheum Dis; 2008 Jan; 67(1):131-3. PubMed ID: 17704064
[TBL] [Abstract][Full Text] [Related]
31. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin.
Vossenaar ER; Després N; Lapointe E; van der Heijden A; Lora M; Senshu T; van Venrooij WJ; Ménard HA
Arthritis Res Ther; 2004; 6(2):R142-50. PubMed ID: 15059278
[TBL] [Abstract][Full Text] [Related]
32. Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.
Kastbom A; Forslind K; Ernestam S; Geborek P; Karlsson JA; Petersson IF; Saevarsdottir S; Klareskog L; van Vollenhoven RF; Lundberg K
Ann Rheum Dis; 2016 Feb; 75(2):356-61. PubMed ID: 25550338
[TBL] [Abstract][Full Text] [Related]
33. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
34. Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles.
Verpoort KN; Cheung K; Ioan-Facsinay A; van der Helm-van Mil AH; de Vries-Bouwstra JK; Allaart CF; Drijfhout JW; de Vries RR; Breedveld FC; Huizinga TW; Pruijn GJ; Toes RE
Arthritis Rheum; 2007 Dec; 56(12):3949-52. PubMed ID: 18050209
[TBL] [Abstract][Full Text] [Related]
35. The use of chimeric vimentin citrullinated peptides for the diagnosis of rheumatoid arthritis.
Malakoutikhah M; Gómara MJ; Gómez-Puerta JA; Sanmartí R; Haro I
J Med Chem; 2011 Nov; 54(21):7486-92. PubMed ID: 21981664
[TBL] [Abstract][Full Text] [Related]
36. Autoantibody and metalloproteinase activity in early arthritis.
Ponikowska M; Świerkot J; Nowak B; Korman L; Wiland P
Clin Rheumatol; 2019 Mar; 38(3):827-834. PubMed ID: 30406565
[TBL] [Abstract][Full Text] [Related]
37. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden.
Kokkonen H; Johansson M; Innala L; Jidell E; Rantapää-Dahlqvist S
Arthritis Res Ther; 2007; 9(3):R56. PubMed ID: 17553139
[TBL] [Abstract][Full Text] [Related]
38. Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis.
Johansson L; Sherina N; Kharlamova N; Potempa B; Larsson B; Israelsson L; Potempa J; Rantapää-Dahlqvist S; Lundberg K
Arthritis Res Ther; 2016 Sep; 18(1):201. PubMed ID: 27605245
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort.
Nicaise-Roland P; Nogueira L; Demattei C; de Chaisemartin L; Rincheval N; Cornillet M; Grootenboer-Mignot S; Dieudé P; Dougados M; Cantagrel A; Meyer O; Serre G; Chollet-Martin S
Ann Rheum Dis; 2013 Mar; 72(3):357-62. PubMed ID: 22580581
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
Bartoloni E; Alunno A; Bistoni O; Bizzaro N; Migliorini P; Morozzi G; Doria A; Mathieu A; Lotzniker M; Allegri F; Riccieri V; Alpini C; Gabrielli A; Tampoia M; Gerli R;
Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
